Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. [electronic resource]
Producer: 20180117Description: 35132-43 p. digitalISSN:- 1949-2553
- Adult
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Ovarian Epithelial
- Clinical Trials, Phase I as Topic
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Proportional Hazards Models
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.